Morgan Stanley’s Verona Pharma VRNA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $17.2M | Sell |
182,330
-1,441,797
|
|
||||
|
2025
Q1 | $103M | Buy |
1,624,127
+140,374
|
|
||||
|
2024
Q4 | $68.9M | Buy |
1,483,753
+892,844
|
|
||||
|
2024
Q3 | $17M | Sell |
590,909
-273,122
|
|
||||
|
2024
Q2 | $12.5M | Buy |
864,031
+530,859
|
|
||||
|
2024
Q1 | $5.36M | Sell |
333,172
-629,220
|
|
||||
|
2023
Q4 | $19.1M | Buy |
962,392
+888,349
|
|
||||
|
2023
Q3 | $1.21M | Sell |
74,043
-6,885
|
|
||||
|
2023
Q2 | $1.71M | Sell |
80,928
-124,968
|
|
||||
|
2023
Q1 | $4.13M | Buy |
205,896
+34,778
|
|
||||
|
2022
Q4 | $4.47M | Buy |
171,118
+166,140
|
|
||||
|
2022
Q3 | $51K | Sell |
4,978
-4,807
|
|
||||
|
2022
Q2 | $41K | Buy |
9,785
+332
|
|
||||
|
2022
Q1 | $47K | Buy |
9,453
+2,185
|
|
||||
|
2021
Q4 | $48K | Sell |
7,268
-926
|
|
||||
|
2021
Q3 | $45K | Buy |
8,194
+4,520
|
|
||||
|
2021
Q2 | $24K | Buy |
3,674
+2,174
|
|
||||
|
2021
Q1 | $13K | Sell |
1,500
-128
|
|
||||
|
2020
Q4 | $12K | Buy |
1,628
+128
|
|
||||
|
2020
Q3 | $9K | Buy |
+1,500
|
|
||||
|
2019
Q2 | – | Sell |
-1
|
|
||||
|
2019
Q1 | $0 | Hold |
1
|
|
||||
|
2018
Q4 | $0 | Hold |
1
|
|
||||
|
2018
Q3 | $0 | Hold |
1
|
|
||||
|
2018
Q2 | $0 | Sell |
1
-200
|
|
||||
|
2018
Q1 | $4K | Buy |
201
+186
|
|
||||
|
2017
Q4 | $0 | Buy |
15
+1
|
|
||||
|
2017
Q3 | $0 | Buy |
+14
|
|